Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Source:http://linkedlifedata.com/resource/pubmed/id/228284

Download in:

View as

General Info

PMID
228284